Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carnamedica is a Polish medical technology company specializing in the development, manufacturing, and distribution of advanced solutions for interventional cardiology, radiology, and vascular surgery. The company is best known for its proprietary Carna line of products, which includes cobalt-chromium coronary stent systems and PTCA balloon catheters designed for minimally invasive cardiovascular procedures. In addition to its own manufacturing capabilities, Carnamedica serves as a major distributor for international medical device brands, providing the Polish healthcare market with specialized tools for neuroradiology and peripheral interventions. Their business model combines technical innovation in vascular scaffolding with a robust supply chain for high-precision surgical equipment. The company is headquartered in Raszyn, near Warsaw, and maintains a significant presence in the Central European medical device sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carnamedica.